Many People Still Unaware Of Telehealth's Efficacy
Despite telehealth’s rise in popularity during the height of COVID-19, many individuals still aren't aware that it's a viable option.
Perrigo Recalls Gerber Good Start SoothePro Powdered Infant Formula
Out of an abundance of caution, the infant formula giant has recalled one of their powdered infant formula products because of a potentially dangerous bacteria.
Sanofi Cuts Insulin Prices, Joining Eli Lilly and Novo Nordisk
The company also will establish a $35 out-of-pocket price cap for for all patients with commercial insurance that use Latnus
Continued Antidepressant Use Helps Pregnant Women Manage Severe Mental Illness
There was a lower probability of initiating psycholeptics and experiencing postpartum psychiatric emergencies in study patients who continued using antidepressants
News Roundup: March 13 to March 17
Your weekly roundup of the latest news from Drug Topics®.
Attempting To Eradicate Polio For Good
Polio prevalence has been reduced by 99.99% in the past 35 years. But the disease continues to exist in countries like Pakistan and Afghanistan, where it seeds outbreaks elsewhere.
FDA Approves Drug Combo for Young Glioma Patients
A combination of dabrafenib with trametinib was approved by the FDA for treatment of pediatric patients 1 year and older with low-grade glioma & BRAF V600E mutation who require systemic therapy.
Meningococcal ABCWY Vaccine Meets Endpoints in Trial
The vaccine, developed by GSK, is "very encouraging" step in fight to treat meningococcal disease
Earlier Use Of Jakafi Leads To Improved Symptoms And Higher Survival In Myelofibrosis Patients
Treating myelofibrosis with Jakafi earlier has shown promise in improving both survival and symptom burden
Combination of Two Drugs Effective In Treating Alopecia
The combination of prednisone and methotrexate provided nearly complete or complete hair regrowth in up to 31.2% of patients with alopecia areata.
US District Judge Hearing Arguments to Potentially Halt Distribution of Abortion Pill Mifepristone
Drug Topics will continue to update this story as new information becomes available.
FDA Authorizes Bivalent Pfizer-BioNTech COVID-19 Vaccine As Booster Dose For Young Children
A new booster shot of the Pfizer-BioNTech COVID-19 vaccine is now available for children aged 6 months to 4 years, in an effort to continue to curb the effects of COVID-19
Fezolinetant Appears Successful In Treating Hot Flashes And Night Sweats
Results from a phase 3 study show that the drug is effective in treating VMS symptoms due to menopause.
VA To Cover Alzheimer's Drug, With Some Exceptions
Per VA regulations, anyone who has had a stroke or seizure within the last year, as well as those with MRIs showing microhemmorrhages, aneurysms, lesions or tumors would be excluded from coverage of the drug, called Leqambi
Health Care Hiring Trends For 2023 And Beyond
How are hiring trends shaping up for the future of health care?
FDA Grants De Novo Approval to Non-Invasive Tinnitus Treatment Device
The product, called Lenire, uses bimodal stimulation and will be available in April 2023
Novo Nordisk To Cut Insulin Prices Up To 75%
According to a company press release, the price reductions will go into effect at the start of 2024
President Biden Releases Op-Ed In New York Times Outlining Future Of Medicare
The President said he will make Medicare “solvent beyond 2050 without cutting a penny in benefits.”
Nasal Spray For Migraines Gets FDA Approval
The spray, called Zavzpret, intends to help individuals who struggle with migraines but can't take oral medication because of nausea or vomiting
PBM Formulary Exclusions List Reaches All-Time High
Critics of PBM's say that the high number of exclusions narrows patient options and make medications financially inaccessible.
News Roundup March 6-March 10
Controversial Preterm Birth Prevention Drug To Be Removed From Market
The drug, called Makena, was intended to stop premature births, but has not been effective in its goal, says the FDA.
Supplemental BLA Accepted For Melanoma Treatment
The FDA agreed to review a supplemental Biologics License Application for Opdivo to treat stage 2B or C, fully resected melanoma.
FDA Sets Target Date To Expand Dwarfism Care Voxzogo To Younger Children
Voxzogo is already available for patients over 5 years with a genetic cause of dwarfism. The PDUFA date is set for Oct. 21, 2023, and will potentially expand the drug to children 5 and under.
FDA Accepts Biologics License Application for Proposed Denosumab Biosimilar
The drug, manufactured by Sandoz, will treat conditions including osteoporosis in postmenopausal women
Rivaroxaban Plus Aspirin Reduces Acute Limb Ischemia After Lower Extremity Revascularization in PAD
Results of an analysis of the VOYAGER PAD clinical trial were presented at ACC.23.
Azithromycin Reduces Risk of Maternal Sepsis, Death in Vaginal Delivery
A single oral dose of azithromycin during labor in women planning vaginal delivery can significantly reduce the risk of maternal sepsis or death
FDA Clears First Commercially Available Blood Test to Evaluate for TBI, Concussion
The test is intended to complement the company’s TBI plasma test, which received FDA clearance in 2021.
Cancer Risk Associated With UV Nail Dryers
The safety of gel manicures is under renewed scrutiny after a new study suggested they can cause DNA damage
Racial, Ethnic Inequities Persist in Diabetes Care
Significant differences in the use of insulin pump and/or CGM technology were noted based on demographic and socioeconomic factors
